BBP News and Press, Virtus LifeSci Biotech Products From 08/11/23

2023-08-11 01:45:00 ET Summary The U.S. healthcare system remains a global outlier in both innovation and cost. The U.S. spends twice as much per capita on healthcare versus its developed-country peers yet life expectancy is lower by 6.3 years. Healthcare companies continue to...

2023-07-25 04:17:00 ET Summary Over the last seven recessionary periods in the U.S., healthcare outperformed the broader market by an average of 10%. Slowing economies call for the resilience that healthcare companies can offer, yet the sector remains at a 10% discount to global e...

2023-07-25 01:30:00 ET Summary Why the stock market gains we're seeing may not be telling the whole story. Investors may have been too focused on market capitalization in the first half. Finding opportunities in the healthcare sector. The strong market performance ...

2023-07-24 22:24:00 ET Summary Equity and fixed income markets experienced heightened volatility amid the Q2 debt-ceiling saga, while currency and derivatives markets were mostly unaffected. Regional banks struggled in Q2, with deposits and witnessed credit spreads widening by 100...

2023-07-23 05:45:00 ET Summary Novartis has signed a $1 billion deal to acquire DTx Pharma - DTx Pharma shareholders will receive $500 million upfront and up to $500 million in milestones. Sichuan Kelun-Biotech completed a $174 million IPO on the Hong Kong Exchange, valuing the co...

2023-07-11 21:25:00 ET Summary Health care’s innovation-driven growth and inherent resilience makes it a natural fit for dividend growth investors, according to Franklin Equity Group. Technology in health care has historically driven a broad range of innovation, from the do...

2023-06-09 07:36:00 ET Summary Healthcare companies are beginning to explore how artificial intelligence might unlock efficiencies for patients and medical systems. Companies that put cash to work by investing in innovation are signaling efforts to secure consistent long-term prof...

2023-06-09 02:00:00 ET Summary Recent clinical trial success for the second significant, disease-modifying drug to treat Alzheimer’s is a critical milestone and a positive sign for the future of neuroscience. Technological advancements, particularly artificial intelligence ...

2023-05-18 03:36:47 ET Summary Several ETFs exist offering investors concentrated biotech exposure that varies in stock selection and weighting schemes. While all of the choices exhibit 90%+ exposure to biotech stocks, only XBI is a true pure-play at nearly 100%. The low relat...

2023-05-17 00:15:00 ET Summary One of the most promising applications of AI in drug discovery is in the identification of new drug targets (AI can be used to discover new drugs). The ability to analyze large amounts of molecular and genomic data quickly and efficiently is somethin...